<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02751060</url>
  </required_header>
  <id_info>
    <org_study_id>TJ-IRB20160305</org_study_id>
    <nct_id>NCT02751060</nct_id>
  </id_info>
  <brief_title>Evaluation of Plasma Non-coding RNAs as Biomarkers in Coronary Heart Disease</brief_title>
  <official_title>Evaluation of Plasma Non-coding RNAs (miRNA-320a) as Biomarkers of Diagnosis, Prognosis and Treatment Effects in Coronary Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tongji Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the expression level of miR-320a are
      effective as biomarker in evaluating the diagnosis, prognosis and treatment effects of
      coronary heart disease.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>April 2016</start_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>the plasma expression of miR-320a in coronary heart disease patients compared to control patients</measure>
    <time_frame>up to 24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of participants with cardiovascular causes of death</measure>
    <time_frame>up to 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of participants with non fatal myocardial infarction or stroke</measure>
    <time_frame>up to 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of participants with re-hospitalization due to cardiovascular causes</measure>
    <time_frame>up to 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of participants with all causes of mortality</measure>
    <time_frame>up to 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of participants with myocardial infarction re-exacerbation or re-hospitalization</measure>
    <time_frame>up to 24 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Coronary Disease</condition>
  <arm_group>
    <arm_group_label>patients with coronary heart disease symptoms</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>patients with coronary heart disease symptoms</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        4000 outpatients or hospitalized patients with coronary heart diseasewill be enrolled in
        this study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18 years of age or older;

          2. the most recent symptoms of coronary heart disease within 7 days;

          3. meet one of the following conditions: A. clinical history of typical ischemic chest
             pain (more than 5 minutes of persistent chest pain); B. serum cardiac biomarkers
             positive (TnT/I or creatine kinase peak greater than 99% of URL); C. Electrocardiogram
             changes of myocardial ischemia.

        Exclusion Criteria:

          1. pregnant women or plan to;

          2. participate in any drug clinical trials within 3 months;

          3. patients with life-threatening complications, or the researchers determined that the
             survival time of patients with no more than 1 years;

          4. serious neurological disease (Alzheimer's disease, Parkinson syndrome, progressive
             lower limbs or deaf patients);

          5. previous history of cancer or tumor, or pathological examination confirmed
             precancerous lesions (such as breast ductal carcinoma in situ, or atypical hyperplasia
             of the cervix);

          6. patients refused to comply with the requirements of this study to complete the
             research work;

          7. according to the researchers, patients can not complete the study or not to comply
             with the requirements of this study (because of the reasons for the management or
             other reasons).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dao Wen Wang, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tongji Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tongji Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2016</study_first_submitted>
  <study_first_submitted_qc>April 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2016</study_first_posted>
  <last_update_submitted>April 25, 2018</last_update_submitted>
  <last_update_submitted_qc>April 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tongji Hospital</investigator_affiliation>
    <investigator_full_name>Dao Wen Wang</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

